Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RGN-259 in Dry Eye Syndrome
NCT01387347Phase 2Completed
- Sponsor
- ReGenTree
- Start
- Aug 2011
- Primary completion
- Oct 2011
- Modality
- Peptides
01
Overview
A Phase 2 trial of timbetasin in dry eye syndrome (DED), sponsored by ReGenTree. Started Aug 2011; status: completed.
02
Drugs
timbetasin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01387347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01387347.